Non-Interventional Consecutive and Prospective Study of e.Motion® PS Pro Prosthesis in the Total Knee Artroplasty
NCT ID: NCT02934802
Last Updated: 2019-04-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
140 participants
OBSERVATIONAL
2016-05-26
2025-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Evaluation of Subchondroplasty in Advanced Knee Osteoarthritis.
NCT06027697
TC-A Registration Study
NCT02139345
MOTO Post-marketing Surveillance Study
NCT04072055
ORIGIN® PS Modular & Associated Instruments
NCT06628050
Study to Assess Exactech's Guided Personalized Surgery eGPS® in Total Knee Arthroplasty
NCT02962362
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Total Knee prothesis e motion PS Pro
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients over 18 for which a Total Knee Prosthesis with e.motion® PS Pro was decided
* Patients willing to participate in a 5 years follow-up
Exclusion Criteria
* Tumor on the concerned knee
* Patient vulnerable and under legal protection
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
BBraun Medical SAS
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
François Boillot
Role: PRINCIPAL_INVESTIGATOR
Groupe hospitalier Paris-St Joseph
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Groupe hospitalier Paris-St Joseph
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AAG-O-H-1420
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.